Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapse. (Q54342441)

28 May 2018

title

Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapse. (English)

1 reference

28 May 2018

Marry M van den Heuvel-Eibrink

1 reference

7

object named as

Marry M van den Heuvel-Eibrink

1 reference

28 May 2018

author name string

Costa Bachas

1

1 reference

28 May 2018

Gerrit Jan Schuurhuis

2

1 reference

28 May 2018

Dirk Reinhardt

3

1 reference

28 May 2018

Ursula Creutzig

4

1 reference

28 May 2018

Zinia J Kwidama

5

1 reference

28 May 2018

C Michel Zwaan

6

1 reference

28 May 2018

Evelina S J M De Bont

8

1 reference

28 May 2018

Sarah Elitzur

9

1 reference

28 May 2018

Carmelo Rizzari

10

1 reference

28 May 2018

Valérie de Haas

11

1 reference

28 May 2018

Martin Zimmermann

12

1 reference

28 May 2018

Jacqueline Cloos

13

1 reference

28 May 2018

Gertjan J L Kaspers

14

1 reference

28 May 2018

language of work or name

English

0 references

publication date

25 June 2014

1 reference

28 May 2018

British Journal of Haematology

published in

1 reference

28 May 2018

volume

166

1 reference

28 May 2018

issue

6

1 reference

28 May 2018

page(s)

902-910

1 reference

28 May 2018

Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia.

cites work

1 reference

Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia

21 January 2018

1 reference

Molecularly targeted therapies for pediatric acute myeloid leukemia: progress to date

21 January 2018

1 reference

Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel

21 January 2018

1 reference

Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?

21 January 2018

1 reference

Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.

21 January 2018

1 reference

Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group

21 January 2018

1 reference

Pediatric acute myeloid leukemia

21 January 2018

1 reference

How I treat paediatric relapsed acute myeloid leukaemia

21 January 2018

1 reference

Pediatric acute myeloid leukemia: towards high-quality cure of all patients

21 January 2018

1 reference

Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group

21 January 2018

1 reference

FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model

21 January 2018

1 reference

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

21 January 2018

1 reference

Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia

21 January 2018

1 reference

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.

21 January 2018

1 reference

Biology, risk stratification, and therapy of pediatric acute leukemias: an update

21 January 2018

1 reference

Cooperating gene mutations in acute myeloid leukemia: a review of the literature.

21 January 2018

1 reference

Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials

21 January 2018

1 reference

ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome

21 January 2018

1 reference

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia

21 January 2018

1 reference

Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.

21 January 2018

1 reference

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

21 January 2018

1 reference

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.

21 January 2018

1 reference

Management of relapsed acute myeloid leukaemia

21 January 2018

1 reference

Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.12989

1 reference

28 May 2018

1 reference

28 May 2018